Gritstone bio, Inc. (GRTSQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
-0.0100 (-50.00%)
Dec 20, 2024, 4:00 PM EST
Gritstone bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 0.5 | 1.33 | 9.27 | 46.72 | 3.46 | 4.37 | Upgrade
|
| Other Revenue | 14.11 | 15.01 | 10.68 | 1.5 | 0.58 | - | Upgrade
|
| Revenue | 14.61 | 16.34 | 19.95 | 48.21 | 4.04 | 4.37 | Upgrade
|
| Revenue Growth (YoY) | 25.09% | -18.05% | -58.63% | 1094.30% | -7.51% | 267.73% | Upgrade
|
| Cost of Revenue | 119.55 | 127.18 | 111.4 | 97.49 | 88.64 | 82.9 | Upgrade
|
| Gross Profit | -104.94 | -110.84 | -91.46 | -49.28 | -84.61 | -78.53 | Upgrade
|
| Selling, General & Admin | 31.52 | 28.78 | 28.97 | 25.93 | 21.41 | 19.41 | Upgrade
|
| Operating Expenses | 31.52 | 28.78 | 28.97 | 25.93 | 21.41 | 19.41 | Upgrade
|
| Operating Income | -136.47 | -139.62 | -120.43 | -75.21 | -106.02 | -97.94 | Upgrade
|
| Interest Expense | -4.81 | -4.04 | -1.24 | -0.04 | -0.01 | - | Upgrade
|
| Interest & Investment Income | 3.45 | 5.2 | 1.98 | 0.16 | 0.72 | 2.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.8 | -0.03 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -133.03 | -138.49 | -119.69 | -75.08 | -105.31 | -95.78 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 1.35 | Upgrade
|
| Pretax Income | -133.03 | -138.49 | -119.69 | -75.08 | -105.31 | -94.43 | Upgrade
|
| Net Income | -133.03 | -138.49 | -119.69 | -75.08 | -105.31 | -94.43 | Upgrade
|
| Net Income to Common | -133.03 | -138.49 | -119.69 | -75.08 | -105.31 | -94.43 | Upgrade
|
| Shares Outstanding (Basic) | 124 | 116 | 91 | 79 | 38 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 124 | 116 | 91 | 79 | 38 | 34 | Upgrade
|
| Shares Change (YoY) | 17.64% | 27.07% | 15.25% | 108.73% | 12.63% | 276.21% | Upgrade
|
| EPS (Basic) | -1.08 | -1.20 | -1.32 | -0.95 | -2.79 | -2.81 | Upgrade
|
| EPS (Diluted) | -1.08 | -1.20 | -1.32 | -0.95 | -2.79 | -2.81 | Upgrade
|
| Free Cash Flow | -112.43 | -126.22 | -121.82 | -56.14 | -92.62 | -101.18 | Upgrade
|
| Free Cash Flow Per Share | -0.91 | -1.09 | -1.34 | -0.71 | -2.45 | -3.02 | Upgrade
|
| Gross Margin | - | - | - | -102.20% | - | - | Upgrade
|
| Operating Margin | -934.05% | -854.26% | -603.80% | -155.99% | -2626.13% | -2243.76% | Upgrade
|
| Profit Margin | -910.56% | -847.34% | -600.09% | -155.73% | -2608.72% | -2163.41% | Upgrade
|
| Free Cash Flow Margin | -769.56% | -772.27% | -610.77% | -116.44% | -2294.20% | -2318.08% | Upgrade
|
| EBITDA | -129.23 | -132.03 | -113.87 | -68.86 | -99.37 | -93.2 | Upgrade
|
| EBITDA Margin | - | - | - | -142.83% | - | - | Upgrade
|
| D&A For EBITDA | 7.23 | 7.59 | 6.56 | 6.35 | 6.64 | 4.75 | Upgrade
|
| EBIT | -136.47 | -139.62 | -120.43 | -75.21 | -106.02 | -97.94 | Upgrade
|
| EBIT Margin | - | - | - | -155.99% | - | - | Upgrade
|
| Revenue as Reported | 14.61 | 16.34 | 19.95 | 48.21 | 4.04 | 4.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.